AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 117 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $17,000 | +6.2% | 875 | +10.1% | 0.00% | – |
| Q3 2019 | $16,000 | -5.9% | 795 | 0.0% | 0.00% | – |
| Q2 2019 | $17,000 | +13.3% | 795 | +6.0% | 0.00% | – |
| Q1 2019 | $15,000 | -50.0% | 750 | -50.0% | 0.00% | – |
| Q4 2018 | $30,000 | +3.4% | 1,500 | 0.0% | 0.00% | – |
| Q3 2018 | $29,000 | -23.7% | 1,500 | -40.0% | 0.00% | -100.0% |
| Q2 2018 | $38,000 | +26.7% | 2,500 | +56.2% | 0.00% | – |
| Q1 2018 | $30,000 | -3.2% | 1,600 | 0.0% | 0.00% | – |
| Q4 2017 | $31,000 | +6.9% | 1,600 | 0.0% | 0.00% | – |
| Q3 2017 | $29,000 | -14.7% | 1,600 | -14.2% | 0.00% | -100.0% |
| Q2 2017 | $34,000 | +3300.0% | 1,864 | +2682.1% | 0.00% | – |
| Q1 2017 | $1,000 | -88.9% | 67 | -86.2% | 0.00% | – |
| Q3 2016 | $9,000 | – | 487 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LAM GROUP, INC. | 128,000 | $5,886,720 | 5.78% |
| Beacon Harbor Wealth Advisors, Inc. | 103,095 | $4,741 | 1.58% |
| Capital Impact Advisors, LLC | 15,304 | $703,831 | 1.18% |
| Quantedge Capital Pte Ltd | 36,389 | $1,673,530 | 0.91% |
| Mesirow Institutional Investment Management, Inc. | 183,805 | $8,453,192 | 0.86% |
| Monashee Investment Management LLC | 39,461 | $1,814,811 | 0.76% |
| OBERWEIS ASSET MANAGEMENT INC/ | 152,500 | $7,013,475 | 0.74% |
| Granite Investment Partners, LLC | 330,911 | $15,218,597 | 0.64% |
| Portolan Capital Management | 132,850 | $6,109,772 | 0.57% |
| SHAKER INVESTMENTS LLC/OH | 20,795 | $956,362 | 0.53% |